Fosun Pharmaceutical: the production line of propofol fumarate tenofovir API, a holding subsidiary, passed the GMP compliance inspection

The Overlooked 120 Million Consumers

Japan is a demanding but high-value market. Chinese sellers are growing fast, yet success requires more than low prices—clear manuals, strong quality, 24/7 service, and trust. Consumption is polarizing, and aging buyers remain active. Long-term branding and localization are key.

Week's Go Global Information Gap (11/23–11/29): The US launched the AI "Genesis Project"

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

China and U.S. Agree to Pause Certain Tariffs and Export Restrictions

​On October 30, China’s Ministry of Commerce (商务部) officially released the outcomes of the China–U.S. trade consultations held in Kuala Lumpur. Building on the consensus reached during the China–U.S. presidential meeting in Busan, the two countries’ economic and trade teams achieved substantive breakthroughs on key issues such as tariffs and export controls, providing a strong boost of confidence to the global economy.

QCraft Debuts at Japan Mobility Show, Starts L4 Robobus Commercial Deployment in Japan

QCraft debuted at the 2025 Japan Mobility Show (49th Tokyo Motor Show), presenting its first mature L4 autonomous products for Japan — the Robobus and its full-stack autonomous driving solution — signaling the start of its commercial rollout in the country.

Autonomous Driving Goes Abroad: Why Singapore Is the First Stop in Southeast Asia

When Chinese autonomous driving technology companies set their sights on Southeast Asia, Singapore almost invariably becomes the “first coordinate” on every roadmap. In 2025, Singapore has offered not only certainty for those planning to enter, but also a stage for those already here.